Wolters Victorien M, van de Nadort Cissy, Gerritsen Susan A M, Kneepkens C M Frank, Ten Kate Fiebo J W, Gijsbers Caroline F M, Schweizer Joachim J, Nikkels Peter G J, Benninga Marc A, Houwen Roderick H J
Department of Paediatric Gastroenterology, University Medical Centre Utrecht, P.O. Box 85090, Utrecht 3508 AB, The Netherlands.
J Pediatr Gastroenterol Nutr. 2009 May;48(5):566-70. doi: 10.1097/MPG.0b013e31818c526b.
In the diagnosis of coeliac disease (CD), gluten challenge is recommended for children under the age of 2 years at initial biopsy. The aim of the study was to investigate the diagnostic yield of gluten challenge in this group of children.
We included children aged 2 years or younger who were analysed for possible CD and who had villous atrophy at initial small bowel biopsy in the period 1993-2004. We subsequently identified all patients who underwent a complete gluten challenge.
We identified 333 children with possible CD. In 100 children (30%), a gluten challenge was performed, with the diagnosis being confirmed in 97. Retrospectively, in 2 of the 3 children without mucosal relapse, data available before gluten challenge did not justify the initial diagnosis of CD. In the third patient, transient gluten intolerance could not be excluded. At first biopsy, the 2 children without mucosal relapse had negative serological parameters, whereas the third patient had IgA antigliadin antibodies, but no IgA anti-endomysium antibodies (EMA). Indeed, all of the patients with EMA at diagnosis had a relapse at gluten challenge.
Routine gluten challenge in children younger than 2 years at initial diagnosis of CD has an extremely low diagnostic yield. We suggest that routine gluten challenge in this group of patients is not necessary when patients have villous atrophy in combination with EMA. Therefore, a revision of the current diagnostic criteria has to be considered.
在乳糜泻(CD)的诊断中,对于初次活检时年龄小于2岁的儿童,推荐进行麸质激发试验。本研究的目的是调查该组儿童中麸质激发试验的诊断价值。
我们纳入了1993年至2004年期间年龄在2岁及以下、因可能患有CD而接受分析且初次小肠活检时有绒毛萎缩的儿童。随后,我们确定了所有接受完整麸质激发试验的患者。
我们确定了333名可能患有CD的儿童。其中100名儿童(30%)进行了麸质激发试验,97名儿童的诊断得到证实。回顾性分析发现,在3名无黏膜复发的儿童中,有2名在麸质激发试验前的现有数据无法支持最初的CD诊断。在第三名患者中,不能排除短暂性麸质不耐受。初次活检时,2名无黏膜复发的儿童血清学指标为阴性,而第三名患者有IgA抗麦醇溶蛋白抗体,但无IgA抗肌内膜抗体(EMA)。事实上,所有诊断时有EMA的患者在麸质激发试验时均出现复发。
对于初次诊断为CD的2岁以下儿童,常规进行麸质激发试验的诊断价值极低。我们建议,当患者既有绒毛萎缩又有EMA时,该组患者无需常规进行麸质激发试验。因此,必须考虑对当前的诊断标准进行修订。